BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32219691)

  • 21. Tumour-infiltrating CD8
    Glaire MA; Domingo E; Sveen A; Bruun J; Nesbakken A; Nicholson G; Novelli M; Lawson K; Oukrif D; Kildal W; Danielsen HE; Kerr R; Kerr D; Tomlinson I; Lothe RA; Church DN
    Br J Cancer; 2019 Sep; 121(6):474-482. PubMed ID: 31388185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy.
    van Baal JOAM; Lok CAR; Jordanova ES; Horlings H; van Driel WJ; Amant FC; Van de Vijver KK
    Virchows Arch; 2020 Oct; 477(4):535-544. PubMed ID: 32179982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic Characteristics of Breast Cancer According to the Infiltrating Immune Cell Subtypes.
    Kim HM; Koo JS
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD47 expression and CD163
    Imam R; Chang Q; Black M; Yu C; Cao W
    BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
    Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
    Leivonen SK; Pollari M; Brück O; Pellinen T; Autio M; Karjalainen-Lindsberg ML; Mannisto S; Kellokumpu-Lehtinen PL; Kallioniemi O; Mustjoki S; Leppä S
    Haematologica; 2019 Feb; 104(2):338-346. PubMed ID: 30237271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein-Barr viral infection in nasopharyngeal carcinoma.
    Huang H; Liu X; Zhao F; Lu J; Zhang B; Peng X; Zhang M; Chen X; Li G; Li X
    Acta Otolaryngol; 2017 Aug; 137(8):888-894. PubMed ID: 28395580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD163
    Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
    Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma.
    Makise N; Morikawa T; Nakagawa T; Ichimura T; Kawai T; Matsushita H; Kakimi K; Kume H; Homma Y; Fukayama M
    Hum Pathol; 2016 Apr; 50():62-9. PubMed ID: 26997439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.
    Nakanishi H; Miyata Y; Mochizuki Y; Yasuda T; Nakamura Y; Araki K; Sagara Y; Matsuo T; Ohba K; Sakai H
    Hum Pathol; 2018 Sep; 79():102-108. PubMed ID: 29787818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.
    Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K
    Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.